LifeTech Scientific Heart R Membranous VSD Asymmetric Occluder
LifeTech Scientific Heart R Membranous VSD Asymmetric Occluder
LifeTech Scientific Heart R Membranous VSD Asymmetric Occluder
Modified Design Self-expandable Double disc occluder made from Nitinol filament weaved struts Shape memory effect and hyper elasticity. PTFE membrane is delicately sewn into the V5D/PDA devices decreasing residual shunts and have good biocompatibility. PET material sewn into ASD device increases the occlusive properties
Compliance with Three-dimensional Anatomy of Heart Modified design parameters. Waist height and edge Occluder morphology: more suitable for clinical needs perfect compliance with heart anatomy. 3 different types of peri-membranous VSD-device
High Rate of Immediate Occluding Low Rate of Long-term Residual Shunt Comply with heart anatomy morphology High rate of immediate occulding. Much faster and denser as endocardium growth decrease residual shunt Minimize the occluder’s stimulation, low incidence of long-term arrhythmia Transcatheter A5D/PDAV/VSD closure with the reports over 98% successful occlusion takes at 13 and 6 months follow-up with low adverse event risk and no residual shunts were found.
LifeTech Scientific Heart R Membranous VSD Asymmetric Occluder
Modified Design Self-expandable Double disc occluder made from Nitinol filament weaved struts Shape memory effect and hyper elasticity. PTFE membrane is delicately sewn into the V5D/PDA devices decreasing residual shunts and have good biocompatibility. PET material sewn into ASD device increases the occlusive properties
Compliance with Three-dimensional Anatomy of Heart Modified design parameters. Waist height and edge Occluder morphology: more suitable for clinical needs perfect compliance with heart anatomy. 3 different types of peri-membranous VSD-device
High Rate of Immediate Occluding Low Rate of Long-term Residual Shunt Comply with heart anatomy morphology High rate of immediate occulding. Much faster and denser as endocardium growth decrease residual shunt Minimize the occluder’s stimulation, low incidence of long-term arrhythmia Transcatheter A5D/PDAV/VSD closure with the reports over 98% successful occlusion takes at 13 and 6 months follow-up with low adverse event risk and no residual shunts were found.
Reviews
There are no reviews yet.